hydroxybenzenoyl benzenoate | 28122-19-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: hydroxybenzenoyl benzenoate
• 英文别名: hydroxybenzoyl benzoate；benzoyl salicylate；O-benzoylsalicylic acid；benzoyl 2-hydroxybenzoate
• CAS: 28122-19-2
• 化学式: C₁₄H₁₀O₄
• 分子量: 242.231
• InChiKey: SBSUGMAHHSEWJB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Metformin Salts of Salicylic Acid and Its Congeners
  申请人：Mylari Banavara L.

  公开号：US20120289485A1

  公开（公告）日：2012-11-15

  The present invention relates to compounds, intermediates used in the preparation of such compounds, processes for the preparation of such compounds of the formula VI and formula VII and such intermediates, pharmaceutical compositions comprising such compounds of the formula VI and such compounds of the formula VII, and the uses of such compounds of the formula VI and such compounds of the formula VII as antidiabetic, pre-antidiabetic, antiobesity and cardioprotective agents.

  本发明涉及化合物、在制备这些化合物中使用的中间体、用于制备公式 VI 和公式 VII 的这些化合物以及这些中间体的过程、包含公式 VI 的这些化合物和公式 VII 的这些化合物的药物组合物，以及公式 VI 的这些化合物和公式 VII 的这些化合物作为抗糖尿病、预防糖尿病、抗肥胖和心脏保护剂的用途。
• Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity
  申请人：——

  公开号：US20040132115A1

  公开（公告）日：2004-07-08

  A method for identifying compounds that can be useful for producing analgesia is disclosed. In particular, the method involves providing a preparation of a cell, that expresses an alpha 1B adrenergic receptor, combining a test compound with the cell preparation, measuring the effect of the test compound on the alpha 1B receptor activity, and evaluating the compound thus identified for analgesic activity.

  本发明揭示了一种用于鉴定可用于产生止痛作用的化合物的方法。具体而言，该方法涉及提供表达α1B肾上腺素能受体的细胞制备，将测试化合物与细胞制备结合，测量测试化合物对α1B受体活性的影响，并评估因此鉴定出的化合物的止痛活性。
• METFORMIN SALTS OF SALICYLIC ACID AND IT CONGENERS
  申请人：Mylari Banavara L.

  公开号：US20130252926A1

  公开（公告）日：2013-09-26

  The present invention relates to compounds, intermediates used in the preparation of such compounds, processes for the preparation of such compounds of the formula VI and formula VII and such intermediates, pharmaceutical compositions comprising such compounds of the formula VI and such compounds of the formula VII, and the uses of such compounds of the formula VI and such compounds of the formula VII as antidiabetic, pre-antidiabetic, antiobesity and cardioprotective agents.

  本发明涉及公式VI和公式VII的化合物及其制备中间体，用于制备这些化合物的过程，包括公式VI的化合物和公式VII的化合物的制药组合物，以及将这些公式VI的化合物和公式VII的化合物用作抗糖尿病、预防糖尿病、抗肥胖和心脏保护剂的用途。
• Process for polymerizing olefins and catalyst for polymerizing olefins
  申请人：MITSUI PETROCHEMICAL INDUSTRIES, LTD.

  公开号：EP0385765A2

  公开（公告）日：1990-09-05

  A catalyst for polymerization of an olefin, said catalyst being formed from [A] a solid titanium catalyst component com­prising magnesium, titanium, halogen and an electron donor as essential ingredients, [B] an organoaluminum compound catalyst com­ponent, and [C] an electron donor catalyst component com­prising at least two electron donors including an electron donor (1) and an electron donor (2), the MFR (a) of homopolypropylene obtained by using the electron donor (1) together with the solid titanium catalyst component [A] and the organoaluminum compound catalyst component [B] has the following relation to the MFR (b) of homo­polypropylene obtained by using the electron donor (2) under the same polymerization conditions as in the case of using the electron donor (1) log [MFR (b)/MFR (a)]≧1.5. This catalyst can give an olefin polymer having a broad molecular weight. Also provided is a process for poly­merizing or copolymerizing an olefin in the presence of the above catalyst.

  一种用于烯烃聚合的催化剂，所述催化剂由以下物质组成 [A] 固态钛催化剂组分，其主要成分包括镁、钛、卤素和电子供体、 [B] 一种有机铝化合物催化剂组分，以及 [C] 电子供体催化剂组分，由至少两个电子供体组成，包括电子供体 (1) 和电子供体 (2)，在与使用电子供体 (1) 相同的聚合条件下，使用电子供体 (1) 与固体钛催化剂组分 [A] 和有机铝化合物催化剂组分 [B] 一起得到的均聚丙烯的 MFR (a) 与使用电子供体 (2) 得到的均聚丙烯的 MFR (b) 具有如下关系 对数[MFR (b)/MFR (a)]≧1.5。 这种催化剂可以得到具有宽分子量的烯烃聚合物。还提供了一种在上述催化剂存在下聚合或共聚烯烃的工艺。
• IMPROVEMENTS IN FOLIAR FERTILIZERS
  申请人：Everris International B.V.

  公开号：EP3915375A1

  公开（公告）日：2021-12-01

  The present invention relates to a foliar fertilizer composition comprising at least one fertilizer and one or more of sun-blocking compounds chosen from the group of kaolin, bentonite, calcium carbonate and organic compounds that block UV radiation. Preferably, the sun-blocking compound is an organic compound that blocks UV radiation, and may be selected from the group of benzophenone type compounds, benzimidazole type compounds, hydroxybenzoyl benzoate type compounds, benzotriazol type compounds, cinnamido type compounds, flavonoids, antioxidants or lignosulfonates.

  本发明涉及一种叶面肥组合物，该组合物包含至少一种肥料和一种或多种遮阳化合物，遮阳化合物选自高岭土、膨润土、碳酸钙和阻挡紫外线辐射的有机化合物。优选地，遮阳化合物是一种阻挡紫外线辐射的有机化合物，可以选自二苯甲酮类化合物、苯并咪唑类化合物、羟基苯甲酰基苯甲酸类化合物、苯并三唑类化合物、肉桂基类化合物、黄酮类化合物、抗氧化剂或木质素磺酸盐。